Nab-Paclitaxel as new Therapeutic Option for Pancreatic Cancer

被引：0
|
作者：
Michl, P. [1 ]
机构：
[1] Univ Marburg, Klin Gastroenterol Endokrinol & Stoffwechsel, D-35043 Marburg, Germany
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2013年 / 51卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：1329 / 1330
页数：2
相关论文
共 50 条
  • [21] Reinitiating nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer
    Borazanci, Erkut
    Schroeder, Katy
    Jameson, Gayle S.
    Ramanathan, Ramesh K.
    Von Hoff, Daniel D.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [22] Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer
    Han, Sung Yong
    Kim, Dong Uk
    Seol, Young Mi
    Kim, Suk
    Lee, Nam Kyung
    Hong, Seung Baek
    Seo, Hyung-Il
    WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (17) : 3718 - 3729
  • [23] Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer
    Sung Yong Han
    Dong Uk Kim
    Young Mi Seol
    Suk Kim
    Nam Kyung Lee
    Seung Baek Hong
    Hyung-Il Seo
    World Journal of Clinical Cases, 2020, (17) : 3718 - 3729
  • [24] EFFICACY AND SAFETY OF NAB-PACLITAXEL IN COMBINATION WITH GEMCITABINE FOR METASTATIC PANCREATIC CANCER
    You, Min Su
    Ryu, Ji Kon
    Kang, Jinwoo
    Choi, Jin Ho
    Choi, Young Hoon
    Huh, Gunn
    Paik, Woo Hyun
    Lee, Sang Hyub
    Kim, Yong-Tae
    GASTROENTEROLOGY, 2018, 154 (06) : S285 - S285
  • [25] Reply: 'Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer'
    Alvarez, R.
    Musteanu, M.
    Garcia-Garcia, E.
    Lopez-Casas, P. P.
    Megias, D.
    Guerra, C.
    Munoz, M.
    Quijano, Y.
    Cubillo, A.
    Rodriguez-Pascual, J.
    Plaza, C.
    de Vicente, E.
    Prados, S.
    Tabernero, S.
    Barbacid, M.
    Lopez-Rios, F.
    Hidalgo, M.
    BRITISH JOURNAL OF CANCER, 2014, 111 (08) : 1677 - 1678
  • [26] Efficacy and safety of Nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer
    Filipazzi, V.
    Dalu, D.
    Isabella, L.
    Tosca, N.
    Ferrario, S.
    Gambaro, A.
    Somma, L.
    Fasola, C.
    Pellegrini, I.
    Bombonati, G.
    Curcio, R.
    Damiani, E.
    Cattaneo, M. T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [27] nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: Real life
    Cidon, E. Una
    Alonso, P.
    ANNALS OF ONCOLOGY, 2020, 31 : S109 - S109
  • [28] Effect of nab-paclitaxel combination chemotherapy on response and survival in pancreatic cancer
    Dean, Andrew Peter
    Cooray, Prasad
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer
    Comandatore, Annalisa
    Immordino, Benoit
    Balsano, Rita
    Capula, Mjriam
    Garajova, Ingrid
    Ciccolini, Joseph
    Giovannetti, Elisa
    Morelli, Luca
    DIAGNOSTICS, 2022, 12 (02)
  • [30] Gemcitabine and nab-paclitaxel combination therapy for the treatment of metastatic pancreatic cancer
    Sasaki, Takashi
    Kanata, Ryo
    Saito, Kei
    Yamada, Ikuhiro
    Matsuyama, Masato
    Ozaka, Masato
    Takano, Kouichi
    Sasahira, Naoki
    ANNALS OF ONCOLOGY, 2016, 27
12345